A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03353675 · COMPLETED
Trial details
- NCT number
- NCT03353675
- Sponsor
- Transgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2019-11-20
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.